Latest Novo Nordisk Stories
The Danish-based synthetic biology company Biosyntia ApS has completed a DKK 12.5 M financing round with Novo Seeds as lead investor. (PRWEB) May 21, 2015
LONDON and NEW YORK, May 20, 2015 /PRNewswire/ -- China, with 100 million diabetics has already outpaced other nations in terms of number of diabetics.
DUBLIN, May 19, 2015 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/9cdqm8/global_insulin) has announced the addition of the "Global
NASHVILLE, Tenn., May 15, 2015 /PRNewswire/ -- Today, new data from the phase 3a SCALE(TM) Obesity and Pre-diabetes trial were presented at the 24(th) Annual Scientific and Clinical Congress of the
Global healthcare company, Novo Nordisk, renewed its partnership with Team Novo Nordisk for an additional
DUBLIN, May 06, 2015 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/7qn2gf/global_insulin)
PLAINSBORO, N.J., April 22, 2015 /PRNewswire/ -- Novo Nordisk today announced that Saxenda(® )(liraglutide [rDNA origin] injection) is now available in the United States.
PLAINSBORO, N.J., April 17, 2015 /PRNewswire/ -- Novo Nordisk is proud to celebrate World Hemophilia Day, which aims to raise awareness of the disease and other inherited bleeding disorders.
DUBLIN, April 15, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/7jbhnz/global) has announced the addition of the "Global Haemophilia
- A handkerchief.
- Specifically— The legendary sweat-cloth; the handkerchief of St. Veronica, according to tradition miraculously impressed with the mask of Christ; also, the napkin about Christ's head (Johu xx. 7).
- In general, any miraculous portrait of Christ.